FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely to a lyophilised formulation containing an influenza vaccine, an aqueous solution prepared by lyophilisation and containing (i) he influenza vaccine, (ii) a hydrophobic amino acid, and (iii) arginine and an acid addition salt thereof; it also concerns a method for preparing the lyophilised formulation containing the influenza vaccine to be desalted.
EFFECT: group of inventions provides preparing the lyophilised formulation wherein the influenza vaccine exhibits improved stability.
15 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2775944C2 |
| VIRRARY-DIMENSIONING PREPARATION AND USE THEREOF | 2013 |
|
RU2686108C2 |
| COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF | 2016 |
|
RU2753246C2 |
| PEPTIDE-BASED COMPOUNDS FOR DIRECTED TRANSPORT TO INTEGRIN RECEPTORS | 2002 |
|
RU2303042C2 |
| STABLE AQUEOUS PROTEIN COMPOSITIONS OF MIA/CD-RAP | 2011 |
|
RU2739078C2 |
| COMPOSITIONS OF ANTIBODIES TO RSV AND METHODS OF THEIR APPLICATION | 2019 |
|
RU2807524C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO SOST, AND ITS USE | 2018 |
|
RU2779430C2 |
| PHARMACEUTICAL COMPOSITION OF FUSION PROTEIN TACI-FC | 2020 |
|
RU2779387C1 |
| MEANS FOR EFFECTIVE CUPPING OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION | 2016 |
|
RU2622980C1 |
| ANTIBACTERIAL PEPTIDES | 2007 |
|
RU2468033C2 |
